Beyond the Scale: Advances in Obesity Pharmacotherapy and Comorbidity Management-12/09/2025-6:00-8:15 PM
Participants will explore the latest advancements in pharmacotherapy for obesity management, focusing not only on weight reduction but also on the broader impact on obesity-related comorbidities. We will review current and emerging pharmacologic treatment options and examine recent evidence highlighting their benefits in improving outcomes for patients with cardiovascular disease, heart failure, obstructive sleep apnea (OSA), and metabolic dysfunction-associated steatohepatitis (MASH). Attendees will leave with practical insights to optimize obesity care and enhance overall cardiometabolic health.
Registration
Last day to register is 12/2/2025